FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981103412> ?p ?o ?g. }

• W1981103412 endingPage "67" @default.
• W1981103412 startingPage "67" @default.
• W1981103412 abstract "So far, we have not performed genetic testing on moderate cancer risk, such as CHEK2 testing for breast cancer. We feel that this would lead to a large number of the population being positive and that it is unlikely that all carriers would be offered surveillance. Furthermore, the economic burden from surveillance for moderate risk may not be acceptable in a situation where patients who already have cancer would not always be able to get the most expensive and most effective treatments available.Allan SpigelmanProfessor University of New South Wales, Surgical Professorial Unit, St Vincent's Hospital Clinical School, NSW, AustraliaCorresponding author: Director Cancer Services St Vincent's and Mater Health Sydney, NSW, Australia, phone: +61283822354; +61283822328, e-mail: ua.moc.stnecnivts@namlegipsaIt is an interesting pilot study that requires replication on a larger scale.Walter WeberBetriebs- und Forschungslaboratorium, Zweckverband Landeswasserversorgung, GermanyCorresponding author: Medical Oncology, Heuberg 16, CH-4051 Basel, e-mail: hc.niweulb@recnacThis is an important step towards defining genetic risk factors of breast cancer. As a medical oncologist I expect that downstream functions of such common genetic variants will be potential targets for new drugs [1]. Old drugs could also become new drugs [2]. Pharmacoge-netics, the hereditary basis for inter-individual differences in drug effect, will predict patients at risk for extreme toxicity and altered efficacy of chemotherapy [3,4].Vladimir ZajacCancer Research Institute, Slovak Academy of Sciences, Laboratory of Cancer Genetics, Bratislava, Slovak RepublicCorresponding author: Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia, e-mail: ks.abvas@cajaz.rimidalvIt is practically impossible to find a paper in which the authors raise the basic issue - why there is such a high frequency of hereditary forms of cancer in the human population. I highly appreciate your approach and courage to go into this basic problem. I think that your hypothesis may bring a new impulse for the solution of this crucial question.I have a feeling that at the present time human genetics, after a very dramatic period of approximately 20 years, is entering a period of recession. The reason is that we are not able to answer the aforementioned question.Why do so many mutations in a very short part of human DNA result in various types of cancer diseases? This is mainly the case of the APC gene in the part of the MCR where there are concentrated about 70% of all APC germ-line mutations. The answer that this part of the DNA is special and is predisposed to mutation is not correct. We need to try to find another explanation. I am trying to do so.I think that you are absolutely right that there should be something common in predisposition to all malignancies. Is this genetic polymorphisms? Probably yes.Like many researchers who are interested in human genetics, I have a hypothesis as well. This idea has developed over many years and I suppose that it may open new perspectives into human genetics. At present I am working experimentally to confirm it. My idea is rather different from yours.So, there are at the moment two hypotheses!!! Interesting!!!And both are from Eastern Europe!!! It is funny that new impulses are coming from this, still underrated part of Europe.Maybe this is the future." @default.
• W1981103412 created "2016-06-24" @default.
• W1981103412 creator A5044989699 @default.
• W1981103412 date "2008-01-01" @default.
• W1981103412 modified "2023-10-12" @default.
• W1981103412 title "Other short opinions/comments on moderate/low cancer genetic risk markers in medical practice and the article Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology by Lubinski et al., Breast Cancer Res Treat 2008 Apr 15" @default.
• W1981103412 cites W1993134078 @default.
• W1981103412 cites W2022995367 @default.
• W1981103412 cites W2093313266 @default.
• W1981103412 cites W2211841583 @default.
• W1981103412 doi "https://doi.org/10.1186/1897-4287-6-2-67" @default.
• W1981103412 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2735388" @default.
• W1981103412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19804598" @default.
• W1981103412 hasPublicationYear "2008" @default.
• W1981103412 type Work @default.
• W1981103412 sameAs 1981103412 @default.
• W1981103412 citedByCount "0" @default.
• W1981103412 crossrefType "journal-article" @default.
• W1981103412 hasAuthorship W1981103412A5044989699 @default.
• W1981103412 hasBestOaLocation W19811034121 @default.
• W1981103412 hasConcept C104317684 @default.
• W1981103412 hasConcept C121608353 @default.
• W1981103412 hasConcept C126322002 @default.
• W1981103412 hasConcept C143998085 @default.
• W1981103412 hasConcept C2779974597 @default.
• W1981103412 hasConcept C47042493 @default.
• W1981103412 hasConcept C512399662 @default.
• W1981103412 hasConcept C530470458 @default.
• W1981103412 hasConcept C54355233 @default.
• W1981103412 hasConcept C60644358 @default.
• W1981103412 hasConcept C71924100 @default.
• W1981103412 hasConcept C86803240 @default.
• W1981103412 hasConceptScore W1981103412C104317684 @default.
• W1981103412 hasConceptScore W1981103412C121608353 @default.
• W1981103412 hasConceptScore W1981103412C126322002 @default.
• W1981103412 hasConceptScore W1981103412C143998085 @default.
• W1981103412 hasConceptScore W1981103412C2779974597 @default.
• W1981103412 hasConceptScore W1981103412C47042493 @default.
• W1981103412 hasConceptScore W1981103412C512399662 @default.
• W1981103412 hasConceptScore W1981103412C530470458 @default.
• W1981103412 hasConceptScore W1981103412C54355233 @default.
• W1981103412 hasConceptScore W1981103412C60644358 @default.
• W1981103412 hasConceptScore W1981103412C71924100 @default.
• W1981103412 hasConceptScore W1981103412C86803240 @default.
• W1981103412 hasIssue "2" @default.
• W1981103412 hasLocation W19811034121 @default.
• W1981103412 hasLocation W19811034122 @default.
• W1981103412 hasLocation W19811034123 @default.
• W1981103412 hasLocation W19811034124 @default.
• W1981103412 hasOpenAccess W1981103412 @default.
• W1981103412 hasPrimaryLocation W19811034121 @default.
• W1981103412 hasRelatedWork W1996721235 @default.
• W1981103412 hasRelatedWork W2116103722 @default.
• W1981103412 hasRelatedWork W2224319365 @default.
• W1981103412 hasRelatedWork W2297592050 @default.
• W1981103412 hasRelatedWork W2365364931 @default.
• W1981103412 hasRelatedWork W2418638721 @default.
• W1981103412 hasRelatedWork W2783129026 @default.
• W1981103412 hasRelatedWork W3130591221 @default.
• W1981103412 hasRelatedWork W3196332669 @default.
• W1981103412 hasRelatedWork W377899687 @default.
• W1981103412 hasVolume "6" @default.
• W1981103412 isParatext "false" @default.
• W1981103412 isRetracted "false" @default.
• W1981103412 magId "1981103412" @default.
• W1981103412 workType "article" @default.